FACT is the FDA has stated it has the power to remove generic non ADT opioids off the market should one or two ADT opioids of the same niche comes to market. Won't happen all at once but Elite is in the Midst of the Perfect storm and REALITY is obvious....Nasrat is moving this company into the multi billion dollar pain market.
News 
Market Data 
Discover 
